Efficacy and Safety of CT-guided Ozone Neurolysis of the Gasserian Ganglion for Idiopathic Trigeminal Neuralgia in Elderly Patients (≥70 Years Old) - A Retrospective Observational Cohort Study

Authors:

Abstract
Objective: To retrospectively analyze the long-term efficacy, safety, and durability of CT-guided ozone neurolysis of the Gasserian Ganglion in elderly patients (≥70 years old) with Idiopathic Trigeminal Neuralgia (ITN). Methods: This was a retrospective, single-center, observational cohort study. Consecutive elderly patients with ITN meeting the inclusion criteria between January 2020 and December 2022 were enrolled. All patients underwent percutaneous puncture of the foramen ovale under CT guidance, followed by injection of 5 mL of a medical-grade ozone-oxygen mixture (concentration: 30 µg/mL) around the Gasserian Ganglion. The primary efficacy endpoint was the change in pain intensity assessed using the Visual Analog Scale (VAS). Secondary endpoints included the Barrow Neurological Institute (BNI) pain intensity score, pain recurrence rate, and patient satisfaction. All perioperative and postoperative complications were systematically recorded. All patients completed a 24-month follow-up period. Results: A total of 85 patients (mean age 76.5±4.2 years) were included. The mean VAS score significantly decreased from 8.2±0.9 at baseline to 2.1±1.5 at 24 months (P<0.001). At the final 24-month follow-up, 69 patients (81.2%) achieved satisfactory pain control (BNI grades I-III), among whom 55 patients (64.7%) were completely pain-free without medication (BNI grade I). Kaplan-Meier survival analysis estimated the recurrence-free survival rates at 12 and 24 months postoperatively to be 85.3% and 78.5%, respectively. The most common complication was transient facial hypesthesia (10 cases, 11.8%), which resolved spontaneously within 24 hours in all instances. No instances of anesthesia dolorosa, keratitis, intracranial hemorrhage, or other serious, permanent complications occurred. Conclusion: CT-guided ozone neurolysis of the Gasserian Ganglion is a safe, effective, and durable minimally invasive method for treating elderly patients with ITN. Its non-neurodestructive nature, excellent safety profile, and repeatability offer a highly valuable therapeutic option for this special patient population, who often have multiple comorbidities and are poor candidates for traditional craniotomy or neuroablative procedures.

This publication has 25 references indexed in Scilit: